期刊文献+

不同剂量STZ诱导小鼠糖尿病模型的发病机制 被引量:40

Pathogenesis of mouse diabetes mellitus models induced by different doses of streptozotocin
下载PDF
导出
摘要 目的:探讨不同剂量链脲佐菌素(STZ)多次注射诱导小鼠糖尿病模型的发生机制以及糖尿病的发生与自身免疫应答的关系。方法:昆明小鼠40只随机分为正常对照组(Ⅰ组)及20、40、80 mg.kg-1STZ组(Ⅱ、Ⅲ、Ⅳ组)。腹腔注射不同剂量STZ诱导小鼠糖尿病作为动物模型。葡萄糖(Glu)测定试剂盒与尿液分析试纸条联合检测小鼠血糖和尿糖的变化,光镜观察胰岛的组织学改变情况,ELISA间接法检测小鼠血清中胰岛素抗体(IAA)的水平,淋巴细胞转化试验(MTT法)检测小鼠胸腺和脾脏的T淋巴细胞功能。结果:对照组血糖基本无变化,模型组血糖值随时间增加而增加;注射STZ后第4周,尿糖结果Ⅰ组均为(-);Ⅱ组中5只(-),其余均>+;Ⅲ组中2只(-),其余均>;Ⅳ组均>。不同剂量STZ诱导小鼠胰岛β细胞损伤的病理改变和程度均有所差异。Ⅱ组和Ⅲ组的IAA高于对照组(P<0.05),而Ⅳ组与对照组比较差异无显著性(P>0.05)。与对照组比较,Ⅱ组和Ⅲ组的脾细胞(成熟的T淋巴细胞)对ConA的刺激表现为功能增强,而胸腺细胞(不成熟的T淋巴细胞)对ConA的刺激则表现为功能降低;但Ⅳ组与对照组比较差异无显著性(P>0.05)。结论:3种剂量STZ均可诱导不同程度的糖尿病发生。大剂量STZ(80 mg.kg-1)可诱导小鼠产生2型糖尿病;而小剂量STZ(20和40 mg.kg-1)则诱导产生1型糖尿病,以40 mg.kg-1STZ诱导的1型糖尿病的效果为最佳。 Objective To explore the pathogenesis of type 1 diabetes mellitus (T1DM) induced by different doses of streptozotocin (STZ) and its relations with autoimmune response. Methods Forly KM mice were divided into control group (group Ⅰ ) and 20, 40, 80 mg·kg^-1 STZ treated groups (group Ⅱ , Ⅲ, Ⅳ). Animal models of diabetes mellitus were induced by different doses of STZ through intra peritoneal injection. Blood and urine glucose (Glu) levels were detected with glucose detecting kit and urine analyzing papers respectively. Pancreatic histological changes of islets were observed under light microscope. The level of insulin autoantibodies (IAA) in serum was detected by indirect ELISA. The functions of T lymphocytes in mouse spleen and thymus were detected by Lymphocytes Proliferation Assay (MTT method). Results The blood glucose in group Ⅰchanged nothing. The blood Glu levels in group Ⅱ and Ⅲ increased as times went by. Four weeks after injection of STZ, the urine Glu in group Ⅰ were all negative, in groupⅡ 5 negative and others 〉 +, in group Ⅲ 2 negative and others 〉++, in group Ⅳ all〉 卌. The changes and degrees of pancreatic islet β cells injured by difference doses of STZ were different. The IAA levels in group Ⅱ and Ⅲ were higher than that in control group (P〈0.05), but there was no difference between group Ⅳ and control group. Spleenocytes (mature T lymphocytes) were highly proliferated by ConA and the thymocytes (immature T lymphocytes) were lowly proliferated by ConA in group Ⅱ and Ⅲ. However, there was no difference between group Ⅳand control group. Conclusion Three different doses of STZ (20, 40, 80 mg· kg^-1) can induce different kinds of DM. High dose (80 mg·kg^-1) STZ injection can induce T2DM in mice, and low dose (20, 40 mg· kg^-1) and multiple injection can induce T1DM. The better dose is 40 mg·kg^-1.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2006年第3期432-435,F0003,共5页 Journal of Jilin University:Medicine Edition
基金 教育部归国人员启动基金资助课题(2002)
关键词 链脲佐菌素 糖尿病 实验性 自身抗体 T淋巴细胞 streptozotocin diabetes mellitus, experimental autoantibodies T-lymphocytes
  • 相关文献

参考文献8

  • 1李文君,李波,寇长贵,刘雅文.非胰岛素依赖型糖尿病易感基因定位研究进展[J].吉林大学学报(医学版),2004,30(6):991-993. 被引量:5
  • 2Sun N, Yang G, Zhao H, et al. Multidose streptozotocin induction of diabetes in BALB/c mice induces a dominant oxidative macrophage and a conversion of TH1 to TH2 phenotypes during disease progression [J]. Mediators Inflamm, 2005, 31 (4):202-209.
  • 3Djordjevic PB,Lalic N,Bumbasirevie V,et al.Human fetal islet transplantation in type 1 diabetics:comparison of immunological effects between multiple implantation regimens [J].Trasplant Proc ,2005,37(10):4440-4445.
  • 4Liberatore Rdel R Jr,Barbosa SF,Alkimin MG,et al.Is immunity in diabetic patients influencing the susceptibility to infections ?Immunoglobulins,complement and phagocytic function in chidren and adolescents with type 1 diabetes mellitus[J].Pediatr Diabetes,2005,6(4):206-212.
  • 5Herold KC,Bluestone JA,Montag AG,et al.Prevention of atoimmune diabetes with nonatiuating anti-CD3 monoclonal antibody[J].Diabetes,1992,41:385-391.
  • 6Szkudelski T.The Mechanism of alloxan and streptozotocin action in B cells of the rat pancreas[J].Physiol Res,2001,50(6):537-546.
  • 7陈继冰,于春雷,刘阳,张医芝,王莉,李一.STZ诱导小鼠糖尿病模型中胸腺异位基因表达的研究[J].免疫学杂志,2006,22(1):37-39. 被引量:3
  • 8刘丹,赵召霞,于春雷,王莉,李一.1型糖尿病与脾脏CD4^+CD25^+调节性T细胞及相关基因Foxp3表达的关系[J].中国临床康复,2005,9(7):45-47. 被引量:9

二级参考文献26

  • 1Jonuleit H, Adema G, Schmitt E. Immune regulation by regulatory T cells: implications for transplantation. Transpl Immunol 2003; 11 (3 - 4): 267 - 76.
  • 2Fontenote JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25 + regulatory T cells. Nat. Immunol(on line) 2003; 4(4): 330 -6.
  • 3Yang Z, Chen M, Fialkow LB, et al. The novel anti-inflammatory compound,lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice. Pancreas 2003; 26(4): e99 - 104.
  • 4Rabinovitch A. Immuno regulatary and cytokine imbalances in the pathogenesis of IDDM. Diabetes 1994; 43:613 - 9.
  • 5Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299(5609): 1057 -61.
  • 6Piccinillo CA, Letterio JJ, et al. CD4 +CD25 + regulatory T cells can mediate suppressor function in the absence of transforming growth factor betal production and responsiveness. J Exp Med 2002; 196 (2): 237 - 46.
  • 7Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155 ( 1 ): 1151 - 64.
  • 8Herold KC, Baumann E, Vezys V, et al. Expression and Immune Response to Islet Antigens following Treatment with Low Dose of Streptozotocin in H-2d Mice. J Autoimmun 1997; 10(1): 17 -25.
  • 9Derbinski J,Schulte A,Kyewski B,et al.Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self[J].Nat Immunol,2001,2 (11):1 032-1 039.
  • 10Herold KC,Bloch TN,Vezys V,et al.Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells[J].Diabetes,1995,44 (3):354-359.

共引文献14

同被引文献374

引证文献40

二级引证文献241

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部